Bontac obtained several invention patent issued

Bontac obtained several invention patent issued by the United States Patent and Trademark Office.Check us 

The three newly authorized U.S. invention patents are related to NMN Powder and NADH Powder in Bontac coenzyme products. Among them:

The US invention patent named “NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) MUTANT AND USE THEREOF (NAMPT) mutants and their applications” protects a biocatalytic method that must be used in the production of NMN. Enzyme-nampt, this NAMPT enzyme independently developed by Bontac has extremely high biocatalytic activity, strong stability and high specificity. Relying on this enzyme, Bontac can cost less Produce higher purity NMN products, combined with the purification section of the late NMN production process protected by the US invention patent named “METHOD FOR PURIFYING BETA-NICOTINAMIDE MONONUCLEOTIDE” (the purification method of β-nicotinamide mononucleotide) In the end, the company successfully produced NMN products with high quality and low price by adopting all-enzyme catalytic technology. Bontac has become a large-scale and mass-produced NMN Powder enterprise!

The US invention patent named “METHOD FOR PURIFYING REDUCED FORM OF β-NICOTINAMIDE ADENINE DINUCLEOTIDE (method for purification of reduced β-nicotinamide adenine dinucleotide)” protects the purification section of the late stage of the NADH production process by biological enzyme catalysis This method provides a technical guarantee for Bangtai Biotech to produce NADH products with a purity of up to 99.9%.